Receptor-dependent and genomic-independent actions of estrogen in vascular protection

Chang Gung Medical Journal

Volumn 25, Issue 10, 2002, Pages 636-644

  Lau, Ying Tung ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Endothelial nitric oxide synthase; Estrogen; Estrogen receptor; Nitric oxide; Phosphatidylinositol 3 kinase; Vascular functions

Indexed keywords

ANTIESTROGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STEROID; UNCLASSIFIED DRUG;

ANIMAL CELL; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ESTROGEN ACTIVITY; NONHUMAN; PROTECTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ENDOTHELIUM, VASCULAR; ESTRADIOL; FEMALE; HUMANS; MALE; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, ESTROGEN; SEX CHARACTERISTICS;

EID: 0036813364     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Isles CG, Hole DJ, Hawthorne VM, Lever AF. Relation between coronary risk and coronary mortality in women of the Refew and Paisely survey: Comparison with men. Lancet 1992;339:702-6.
2. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Preventive Med 1991;20:47-63.
3. Grady D, Rubin SM, Petitti DB. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37.
4. Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Curr Opin Cardiol 1994;9:619-26.
5. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J 1996;10:615-24.
6. Nilsson S, Makela S, Treuter E. Mechanisms of estrogen action. Physiol. Rev 2001;81:1535-65.
7. Kelly MJ, Levin ER. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 2001;12: 152-6.
8. Selzman CH, Whitehill TA, Shames BD, Pulido EJ, Cain BC, Harken AH. The biology of estrogen-mediated repair of cardiovascular injury. Ann Thorac Surg 1998;65:868-74.
9. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. New Engl J Med 1999;340:1801-11.
10. Mangelsdort DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. The nuclear receptor superfamily: The second decade. Cell 1995;83:835-39.
11. Kelly MJ, Moss RL, Dudley CA. Differential sensitivity of preoptic-septal neurons to microelectrophoresed estrogen during the estrous cycle. Brain Res 1976;114:152-7.
12. Kelly MJ, Wagner EJ. Estrogen modulation of G-proteincoupled receptors. Trends Endocrinol Metab 1999;10: 369-74.
13. Michel T, Feron O. Nitric oxide and nitric oxide synthases. J Clin Invest 1997;100:2146-52.
14. Shimokawa H. Primary endothelial dysfunction: Atherosclerosis. J Mol Cell Cardiol 1999;31:23-37.
15. Boulanger CM. Secondary endothelial dysfunction: Hypertension and heart failure. J Mol Cell Cardiol 1999; 31:39-49.
16. Ross R. Atherosclerosis - An inflammatory disease. New Engl J Med 1999;340:115-25.
17. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-8.
18. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 2000;87:677-82.
19. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999;103:401-6.
20. Russell KS, Haynes MP, Caulin-Glaser T, Rosneck J, Sessa WC, Bender JR. Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. J Biol Chem 2000;275:5026-30.
21. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000;407:538-41.
22. Russell KS, Haynes MP, Sinha D, Clerisme E, Bender JR. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA 2000;97:5930-5.
23. Shigematsu K, Koyama H, Olson NE, Cho A, Reidy MA. Phosphatidylinositol 3-kinase signaling is important for smooth muscle cell replication after arterial injury. Vasc Biol 2000;20:2373-8.
24. Falkenstein E. Multiple actions of steroid hormones - A focus on rapid, nongenomic effects. Pharmacol Rev 2000;52:513-56.
25. Cantrell DA. Phosphoinositide 3-kinase signaling pathways. J Cell Sci 2001;114:1439-45.
26. Farese RV. Insulin-sensitive phospholipid signaling systems and glucose transport. Exp Biol Med 2001;226:283-95.
27. Vanhaesebroeck B, Waterfield MD. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 1999;253:239-54.
28. Rameh LE, Cantley LC. The role of phosphoinositide 3kinase lipid products in cell function. J Biol Chem 1999;274:8347-50.
29. Cohen P, Alessi DR, Cross DAE. PDK1, one of the missing links in insulin signal transduction? FEBS Letters. 1997;410:3-10.
30. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999;399:597-601.
31. Gallis B, Corthals GL, Goodlett DR, Ueba H, Kim F, Presnell SR, Figeys D, Harrison DG, Berk BC, Aebersold R, Corson MA. Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J Biol Chem 1999;274:30101-8.
32. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999;399:601-5.
33. Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997;100:3131-9.
34. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. J Clin Invest 1996;98:894-8.
35. Saward L, Zahradka P. Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res 1997;81:249-57.
36. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, Griendling KK. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 1999;274:22699-704.
37. Nishimatsu H, Suzuki E, Nagata D, Moriyama N, Satonaka H, Walsh K, Saata M, Kangawa K, Matsuo H, Goto A, Kitamura T, Hirata Y. Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase/Akt-dependent pathway in rat aorta. Circ Res 2001;89:63-70.
38. Miller VM. Gender and vascular reactivity. Lupus. 1999;8:409-15.
39. Selzman CH, Whitehill TA, Shames BD, Pulido EJ, Cain BC, Harken AH. The biology of estrogen-mediated repair of cardiovascular injury. Ann Thorac Surg 1998;65:868-74.
40. Nadal A, Ropero AB, Fuentes E, Soria B. The plasma membrane estrogen receptor: Nuclear or unclear? Trends Pharmacol Sci 2001;22:597-9.
41. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925-30.
42. Kuiper GG. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863-70.
43. Paech K. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997;277:1508-10.
44. Lindner V. Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ Res 1998;83:224-9.
45. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994;89:1943-50.
46. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR, Lubahn DB, O'Donnell TF, Korach KS, Mendelsohn ME. Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice. Nature Medicine 1997;3:545-8.
47. Karas RH, Schulten H, Pare G, Aronovitz MJ, Ohlsson C, Gustafsson JA, Mendelsohn ME. Effects of estrogen on the vascular injury response in estrogen receptor α,β (Double) knockout mice. Circ Res 2001;89:534-9.
48. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren, Smithies O, Gustafsson JA, Mendelsohn ME. Abnormal vascular function and hypertension in mice deficient in estrogen receptor β. Science 2002;295:505-8.
49. Darblade B, Pendaries C, Krust A, Dupont S, Fouque MJ, Rami J, Chambon P, Bayard F, Arnal JF. Estradiol alters nitric oxide production in the mouse aorta through the α-, but not β-, estrogen receptor. Circ Res 2002;90:413-9.
50. Xin HB, Senbonmatsu T, Cheng DS, Wang YX, Copello JA, Ji GJ, Coller ML, Deng KY, Jeyakumar LH, Magnuson MA, Inagami T, Kotlikoff MI, Fleischer S. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature 2002;416:334-7.
51. Hodgin JB, Krege JH, Reddick RL, Korach KS, Smithies O and Maeda N. Estrogen receptor α is a major mediator of 17β-estradiol's atheroprotective effects on lesion size in apoe-/-mice. J Clin Invest 2001;107:333-40.
52. Barrett-Connor E. Sex differences in coronary heart disease. Circulation 1997;95:252-64.
53. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 1998;19:55-72.
54. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000;133:933-41.
55. Manson JE, Martin KA. Postmenopausal hormonereplacement therapy. New Engl J Med 2001;345:34-40.
56. Mosca L, Collins P, Herrington DM, Mendelsohn ME, Pasternak RC, Robertson RM, Schenck-Gustafsson K, Smith SC, Taubert KA, Wenger NK. Hormone replacement therapy and cardiovascular disease. Circulation 2001;104:499-507.
57. Razandi M, Pedram A and Levin ER. Estrogen signals to the preservation of endothelial cell form and function. J Biol Chem. 2000;275:38540-6.
58. 2+ mobilization. Circ Res 1997;81:885-92.
59. +- and phosphatidylinositol 3-kinase-dependent nitric oxide generation in lung endothelial cells in situ with ischemia. J Biol Chem. 2000;275:39807-10.
60. Igarashi J and Michel T. Sphingosine 1-phosphate and isoform-specific activation of phosphoinositide 3-kinase β. J Biol Chem. 2001;276:36281-8.
61. 2+ independent nitric oxide synthase by 17β-estradiol in post-ischemic rat heart. Cardiovascular Res 2000;46:111-8.